According to the research, a group of autoantibodies against tumor-associated antigens, such as Sui1, p62, RalA, p53, NY-ESO-1, and c-myc, had an additive effect with AFP in detecting HCC [38]. Here, RALA is linked to hepatocellular carcinoma.